News

Innovation Idolatry

July 02, 2023

If we view a change opposite of one’s interest as antithetical to innovation, we risk losing sight of our ultimate goal.

Drug Pricing’s Static Changes

July 02, 2023

The debate surrounding drug pricing changes rages on.

Frontrunner in Therapies for Complement-Mediated Diseases

July 02, 2023

A novel complement therapeutic CTx001 offers a novel approach to treating geographic atrophy.

Donaldson Company Acquires Univercells Technologies for €136 Million

June 30, 2023

Donaldson Company’s €136 million (US$148 million) acquisition of Univercells is designed to broaden its portfolio of biomanufacturing solutions.

FDA Approves UCB Generalized Myasthenia Gravis Treatment

June 30, 2023

UCB’s rozanolixizumab-noli is approved for treatment of generalized myasthenia gravis in certain adult patient groups.

Tower Cold Chain Expands to American Center of Excellence

June 29, 2023

Tower Cold Chain will soon open its new headquarters in Philadelphia.

GSK Acquires BELLUS Health

June 29, 2023

This arrangement was approved by the shareholders at BELLUS on June 16, 2023, according to a company press release.

FDA Approves Pfizer Human Growth Hormone Analog

June 29, 2023

FDA approved Pfizer’s once-weekly human growth hormone analog for treatment of growth failure in pediatric patients.

NCI Launches Persistent Poverty Initiative

June 29, 2023

The persistent poverty initiative aims to fight the cumulative effects of persistent poverty on cancer outcomes.

Sobi and CTI BioPharma Complete $1.7 Billion Acquisition Deal

June 29, 2023

Sobi has officially acquired CTI, a biopharma company focused on blood related cancers and rare diseases, in a merger valued at approximately $1.7 billion.